(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Advancement and Effect of Dental Embed Innovation on Oral Wellbeing - 2The Appearance of Experience: Embracing the Reduced Portage Horse
- 3Robert Pattinson claims he's a pathological liar. What 'The Drama' star has said about his 'shtick'
- 4Tesla plans to expand production at German car plant
- 5Comet MAPS faces a make-or-break moment as it dives toward the sun on April 4 — could it shine in the daytime sky?
- Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
- Concern for couple jailed in Tehran as British embassy closes
- NASA’s history-making moon mission aims to send the first woman and person of color to deep space
- German journalists' union condemns attack on reporters in village
- NASA counts down for first crewed lunar mission in half a century
- SpaceX launches Italian Earth-observing satellite to orbit on the 1st mission of 2026 (video)
- The Fate of Rest: Patterns in Shrewd Beds
- Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts.
- Launch pad damaged as Russian rocket blasts off for space station, agency says
